GSEP
ARKG icon

Golden State Equity Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History

Golden State Equity Partners’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,000
Closed -$26.4K – 428
2026
Q1 		$26.4K Buy
+1,000
New +$29.3K ﹤0.01% 1032

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Golden State Equity Partners's ARKG Position: Q2 2026 in Review

Golden State Equity Partners sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 1,000 shares — an estimated $26.4K sold.

Golden State Equity Partners first reported a position in ARKG in Q1 2026 and held it in 1 quarter. The position peaked at $26.4K in Q1 2026. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Golden State Equity Partners reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Golden State Equity Partners sold 1,000 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $26.4K.
  • Golden State Equity Partners first reported a position in ARK Genomic Revolution ETF in Q1 2026 and held it in 1 quarter.
  • Golden State Equity Partners's ARK Genomic Revolution ETF position peaked at $26.4K in Q1 2026.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.